Publications

• 1. Khan L
  2. Derksen T
  3. Redmond D
  4. Storek J
  5. Durand C
  6. Gniadecki R
  7. Korman B
  8. Cohen Tervaert JW
  9. D'Aubeterre A
  10. Osman MS
  11. Willis LM
  The cancer-associated glycan polysialic acid is dysregulated in systemic sclerosis and is associated with fibrosis.; Journal of autoimmunity; Vol 140, pp. 103110. 2023 Sep 22.
• 1. Kenney HM
  2. Rangel-Moreno J
  3. Peng Y
  4. Chen KL
  5. Bruno J
  6. Embong A
  7. Pritchett E
  8. Fox JI
  9. Becerril-Villanueva E
  10. Gamboa-Domínguez A
  11. Quataert S
  12. Muthukrishnan G
  13. Wood RW
  14. Korman BD
  15. Anolik JH
  16. Xing L
  17. Ritchlin CT
  18. Schwarz EM
  19. Wu CL
  Multi-omics analysis identifies IgG2b class-switching with ALCAM-CD6 co-stimulation in joint-draining lymph nodes during advanced inflammatory-erosive arthritis.; Frontiers in immunology; Vol 14, pp. 1237498. 2023 Aug 25.
• 1. Korman BD
  2. Lachant DJ
  3. Castelino FV
  Pulmonary Hypertension: How to Best Treat the Different Scleroderma Phenotypes?; Rheumatic diseases clinics of North America; Vol 49(2), pp. 345-357. 2023 May.
• 1. Murphy SL
  2. Chen YT
  3. Lee YC
  4. Carns M
  5. Aren K
  6. Korman B
  7. Hinchcliff M
  8. Varga J
  Differences in symptom experience among patients with systemic sclerosis: a cluster analytic approach to identifying subgroups.; Rheumatology (Oxford, England); Vol 62(SI), pp. SI64-SI73. 2023 Feb 06.
• 1. Kenney HM
  2. Wood RW
  3. Ramirez G
  4. Bell RD
  5. Chen KL
  6. Schnur L
  7. Rahimi H
  8. Korman BD
  9. Xing L
  10. Ritchlin CT
  11. Schwarz EM
  12. Cole CL
  Implementation of automated behavior metrics to evaluate voluntary wheel running effects on inflammatory-erosive arthritis and interstitial lung disease in TNF-Tg mice.; Arthritis research & therapy; Vol 25(1), pp. 17. 2023 Feb 02.
• 1. Yang MM
  2. Balmert LC
  3. Marangoni RG
  4. Carns M
  5. Hinchcliff M
  6. Korman BD
  7. Varga J
  Circulating CTRP9 Is Associated With Severity of Systemic Sclerosis-Associated Interstitial Lung Disease.; Arthritis care & research; Vol 75(1), pp. 152-157. 2022 Aug 24.
• 1. Kruzer K
  2. Goncalves Marangoni R
  3. Heckler I
  4. Elhage A
  5. Varga J
  6. Hinchcliff M
  7. Carns M
  8. Aren K
  9. Wielgosz A
  10. Nuzzo M
  11. Venkataraman I
  12. Korman B
  Clinical and Autoantibody Associations in Antinuclear Antibody-Positive Systemic Sclerosis Lacking Prototypic Autoantibodies.; Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases; Vol 29(1), pp. 47-51. 2022 Jun 28.
• 1. Roberson EDO
  2. Carns M
  3. Cao L
  4. Aren K
  5. Goldberg IA
  6. Morales-Heil DJ
  7. Korman BD
  8. Atkinson JP
  9. Varga J
  Alterations of the Primary Cilia Gene SPAG17 and SOX9 Locus Noncoding RNAs Identified by RNA-Sequencing Analysis in Patients With Systemic Sclerosis.; Arthritis & rheumatology (Hoboken, N.J.); Vol 75(1), pp. 108-119. 2022 Jan 29.
• 1. Marangoni RG
  2. Datta P
  3. Paine A
  4. Duemmel S
  5. Nuzzo M
  6. Sherwood L
  7. Varga J
  8. Ritchlin C
  9. Korman BD
  Thy-1 plays a pathogenic role and is a potential biomarker for skin fibrosis in scleroderma.; JCI insight; Vol 7(19). 2022 Jan 10.
• 1. Marangoni RG
  2. Korman BD
  3. Parra ER
  4. Velosa APP
  5. Barbeiro HV
  6. Martins V
  7. Dos Santos ABG
  8. Soriano F
  9. Teodoro WR
  10. Silva PL
  11. Tourtellotte W
  12. Capelozzi VL
  13. Varga J
  14. Yoshinari NH
  Pathological pulmonary vascular remodeling is induced by type V collagen in a model of scleroderma.; Pathology, research and practice; Vol 220. 2021 Feb 19.
• 1. De Pieri A
  2. Korman BD
  3. Jüngel A
  4. Wuertz-Kozak K
  Engineering Advanced In Vitro Models of Systemic Sclerosis for Drug Discovery and Development.; Advanced biology; Vol 5(4), pp. e2000168. 2021 Feb 15.
• 1. De Pieri A
  2. Korman B
  3. Jüngel A
  4. Wuertz-Kozak K
  Engineering Advanced In Vitro Models of Systemic Sclerosis for Drug Discovery and Development.; Advanced Biosystems.. 2021 Jan 01.
• 1. Shi B
  2. Wang W
  3. Korman B
  4. Kai L
  5. Wang Q
  6. Wei J
  7. Bale S
  8. Marangoni RG
  9. Bhattacharyya S
  10. Miller S
  11. Xu D
  12. Akbarpour M
  13. Cheresh P
  14. Proccissi D
  15. Gursel D
  16. Espindola-Netto JM
  17. Chini CCS
  18. de Oliveira GC
  19. Gudjonsson JE
  20. Chini EN
  21. Varga J
  Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis.; iScience; Vol 24(1). 2021 Jan 22.
• 1. Marangoni RG
  2. Korman B
  3. Varga J
  Adipocytic Progenitor Cells Give Rise to Pathogenic Myofibroblasts: Adipocyte-to-Mesenchymal Transition and Its Emerging Role in Fibrosis in Multiple Organs.; Current rheumatology reports; Vol 22(11). 2020 Sep 25.
• 1. Bell RD
  2. White RJ
  3. Garcia-Hernandez ML
  4. Wu E
  5. Rahimi H
  6. Marangoni RG
  7. Slattery P
  8. Duemmel S
  9. Nuzzo M
  10. Huertas N
  11. Yee M
  12. O'Reilly MA
  13. Morrell C
  14. Ritchlin CT
  15. Schwarz EM
  16. Korman BD
  TNF Induces Obliterative Pulmonary Vascular Disease in a Novel Model of Connective Tissue Disease Associated Pulmonary Arterial Hypertension (CTD-PAH).; Arthritis & rheumatology (Hoboken, N.J.). 2020 May 10.
• 1. Lemay M
  2. Korman B
  3. Hammert W
  4. White RJ
  5. Lachant D
  Combination treprostinil with sympathectomy and vascular reconstruction to treat recurrent digital ulcer disease.; Clinical and experimental rheumatology. 2020 Apr 15.
• 1. Gourh P
  2. Safran SA
  3. Alexander T
  4. Boyden SE
  5. Morgan ND
  6. Shah AA
  7. Mayes MD
  8. Doumatey A
  9. Bentley AR
  10. Shriner D
  11. Domsic RT
  12. Medsger TA
  13. Ramos PS
  14. Silver RM
  15. Steen VD
  16. Varga J
  17. Hsu V
  18. Saketkoo LA
  19. Schiopu E
  20. Khanna D
  21. Gordon JK
  22. Kron B
  23. Criswell LA
  24. Gladue H
  25. Derk CT
  26. Bernstein EJ
  27. Bridges SL
  28. Shanmugam VK
  29. Kolstad KD
  30. Chung L
  31. Kafaja S
  32. Jan R
  33. Trojanowski M
  34. Goldberg A
  35. Korman BD
  36. Steinbach PJ
  37. Chandrasekharappa SC
  38. Mullikin JC
  39. Adeyemo A
  40. Rotimi C
  41. Wigley FM
  42. Kastner DL
  43. Boin F
  44. Remmers EF
  HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry.; Proceedings of the National Academy of Sciences of the United States of America; Vol 117(1). 2020 Jan 07.
• 1. Mitchell DC
  2. Agnihothri R
  3. Scott GA
  4. Korman B
  5. Richardson CT
  A case of concurrent systemic sclerosis and scleredema.; JAAD case reports; Vol 5(11). 2019 Nov.
• 1. Korman B
  Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis.; Translational research : the journal of laboratory and clinical medicine; Vol 209. 2019 Jul.
• 1. Gourh P
  2. Remmers EF
  3. Boyden SE
  4. Alexander T
  5. Morgan ND
  6. Shah AA
  7. Mayes MD
  8. Doumatey A
  9. Bentley AR
  10. Shriner D
  11. Domsic RT
  12. Medsger TA
  13. Steen VD
  14. Ramos PS
  15. Silver RM
  16. Korman B
  17. Varga J
  18. Schiopu E
  19. Khanna D
  20. Hsu V
  21. Gordon JK
  22. Saketkoo LA
  23. Gladue H
  24. Kron B
  25. Criswell LA
  26. Derk CT
  27. Bridges SL
  28. Shanmugam VK
  29. Kolstad KD
  30. Chung L
  31. Jan R
  32. Bernstein EJ
  33. Goldberg A
  34. Trojanowski M
  35. Kafaja S
  36. Maksimowicz-McKinnon KM
  37. Mullikin JC
  38. Adeyemo A
  39. Rotimi C
  40. Boin F
  41. Kastner DL
  42. Wigley FM
  Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans.; Arthritis & rheumatology (Hoboken, N.J.); Vol 70(10). 2018 Oct.
• 1. Korman B
  2. Marangoni RG
  3. Lord G
  4. Olefsky J
  5. Tourtellotte W
  6. Varga J
  Adipocyte-specific Repression of PPAR-gamma by NCoR Contributes to Scleroderma Skin Fibrosis.; Arthritis research & therapy; Vol 20(1). 2018 Jul 11.
• 1. Korman B
  2. Alejo R
  3. Sudhakar D
  4. Hinchcliff M
  5. Agrawal R
  6. Varga J
  7. Marangoni RG
  The novel adipokine C1q-TNF related protein 9 (CTRP9) is elevated in systemic sclerosis-associated interstitial lung disease.; Clinical and experimental rheumatology; Vol 36 Suppl 113(4). 2018 Jul.
• 1. Marangoni RG
  2. Masui Y
  3. Fang F
  4. Korman B
  5. Lord G
  6. Lee J
  7. Lakota K
  8. Wei J
  9. Scherer PE
  10. Otvos L
  11. Yamauchi T
  12. Kubota N
  13. Kadowaki T
  14. Asano Y
  15. Sato S
  16. Tourtellotte WG
  17. Varga J
  Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target.; Scientific reports; Vol 7(1). 2017 Jun 30.
• 1. Wei J
  2. Zhu H
  3. Lord G
  4. Bhattachayya M
  5. Jones BM
  6. Allaway G
  7. Biswal SS
  8. Korman B
  9. Marangoni RG
  10. Tourtellotte WG
  11. Varga J
  Nrf2 exerts cell-autonomous antifibrotic effects: compromised function in systemic sclerosis and therapeutic rescue with a novel heterocyclic chalcone derivative.; Translational research : the journal of laboratory and clinical medicine; Vol 183. 2017 May.
• 1. Korman BD
  2. Marangoni RG
  3. Hinchcliff M
  4. Shah SJ
  5. Carns M
  6. Hoffmann A
  7. Ramsey-Goldman R
  8. Varga J
  Brief Report: Association of Elevated Adipsin Levels With Pulmonary Arterial Hypertension in Systemic Sclerosis.; Arthritis & rheumatology (Hoboken, N.J.); Vol 69(10). 2017 Jan.
• 1. Korman B
  2. Wei J
  3. Laumann A
  4. Ferguson P
  5. Varga J
  Mutation in LEMD3 (Man1) Associated with Osteopoikilosis and Late-Onset Generalized Morphea: A New Buschke-Ollendorf Syndrome Variant.; Case reports in dermatological medicine; Vol 2016. 2016.
• 1. Marangoni RG
  2. Korman BD
  3. Allanore Y
  4. Dieude P
  5. Armstrong LL
  6. Rzhetskaya M
  7. Hinchcliff M
  8. Carns M
  9. Podlusky S
  10. Shah SJ
  11. Ruiz B
  12. Hachulla E
  13. Tiev K
  14. Cracowski JL
  15. Varga J
  16. Hayes MG
  A candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) gene and systemic sclerosis.; Arthritis research & therapy; Vol 17. 2015 May 19.
• 1. Marangoni RG
  2. Korman BD
  3. Wei J
  4. Wood TA
  5. Graham LV
  6. Whitfield ML
  7. Scherer PE
  8. Tourtellotte WG
  9. Varga J
  Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors.; Arthritis & rheumatology (Hoboken, N.J.); Vol 67(4). 2015 Apr.
• 1. Korman BD
  2. Criswell LA
  Recent advances in the genetics of systemic sclerosis: toward biological and clinical significance.; Current rheumatology reports; Vol 17(3). 2015 Mar.
• 1. Korman BD
  2. Huang CC
  3. Skamra C
  4. Wu P
  5. Koessler R
  6. Yao D
  7. Huang QQ
  8. Pearce W
  9. Sutton-Tyrrell K
  10. Kondos G
  11. Edmundowicz D
  12. Pope R
  13. Ramsey-Goldman R
  Inflammatory expression profiles in monocyte-to-macrophage differentiation in patients with systemic lupus erythematosus and relationship with atherosclerosis.; Arthritis research & therapy; Vol 16(4). 2014 Jul 10.
• 1. Remmers EF
  2. Cosan F
  3. Kirino Y
  4. Ombrello MJ
  5. Abaci N
  6. Satorius C
  7. Le JM
  8. Yang B
  9. Korman BD
  10. Cakiris A
  11. Aglar O
  12. Emrence Z
  13. Azakli H
  14. Ustek D
  15. Tugal-Tutkun I
  16. Akman-Demir G
  17. Chen W
  18. Amos CI
  19. Dizon MB
  20. Kose AA
  21. Azizlerli G
  22. Erer B
  23. Brand OJ
  24. Kaklamani VG
  25. Kaklamanis P
  26. Ben-Chetrit E
  27. Stanford M
  28. Fortune F
  29. Ghabra M
  30. Ollier WE
  31. Cho YH
  32. Bang D
  33. O'Shea J
  34. Wallace GR
  35. Gadina M
  36. Kastner DL
  37. Gül A
  Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease.; Nature genetics; Vol 42(8). 2010 Aug.
• 1. Korman BD
  2. Tyler KL
  3. Korman NJ
  Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists.; Archives of dermatology; Vol 145(8). 2009 Aug.
• 1. Aksentijevich I
  2. Masters SL
  3. Ferguson PJ
  4. Dancey P
  5. Frenkel J
  6. van Royen-Kerkhoff A
  7. Laxer R
  8. Tedgård U
  9. Cowen EW
  10. Pham TH
  11. Booty M
  12. Estes JD
  13. Sandler NG
  14. Plass N
  15. Stone DL
  16. Turner ML
  17. Hill S
  18. Butman JA
  19. Schneider R
  20. Babyn P
  21. El-Shanti HI
  22. Pope E
  23. Barron K
  24. Bing X
  25. Laurence A
  26. Lee CC
  27. Chapelle D
  28. Clarke GI
  29. Ohson K
  30. Nicholson M
  31. Gadina M
  32. Yang B
  33. Korman BD
  34. Gregersen PK
  35. van Hagen PM
  36. Hak AE
  37. Huizing M
  38. Rahman P
  39. Douek DC
  40. Remmers EF
  41. Kastner DL
  42. Goldbach-Mansky R
  An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist.; The New England journal of medicine; Vol 360(23). 2009 Jun 04.
• 1. Lee HS
  2. Korman BD
  3. Le JM
  4. Kastner DL
  5. Remmers EF
  6. Gregersen PK
  7. Bae SC
  Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations.; Arthritis and rheumatism; Vol 60(2). 2009 Feb.
• 1. Korman BD
  2. Seldin MF
  3. Taylor KE
  4. Le JM
  5. Lee AT
  6. Plenge RM
  7. Amos CI
  8. Criswell LA
  9. Gregersen PK
  10. Kastner DL
  11. Remmers EF
  The chromosome 7q region association with rheumatoid arthritis in females in a British population is not replicated in a North American case-control series.; Arthritis and rheumatism; Vol 60(1). 2009 Jan.
• 1. Parker SR
  2. Dyson S
  3. Brisman S
  4. Pennie M
  5. Swerlick RA
  6. Khan R
  7. Manos S
  8. Korman BD
  9. Xia Z
  10. Korman NJ
  Mortality of bullous pemphigoid: an evaluation of 223 patients and comparison with the mortality in the general population in the United States.; Journal of the American Academy of Dermatology; Vol 59(4). 2008 Oct.
• 1. Raychaudhuri S
  2. Remmers EF
  3. Lee AT
  4. Hackett R
  5. Guiducci C
  6. Burtt NP
  7. Gianniny L
  8. Korman BD
  9. Padyukov L
  10. Kurreeman FA
  11. Chang M
  12. Catanese JJ
  13. Ding B
  14. Wong S
  15. van der Helm-van Mil AH
  16. Neale BM
  17. Coblyn J
  18. Cui J
  19. Tak PP
  20. Wolbink GJ
  21. Crusius JB
  22. van der Horst-Bruinsma IE
  23. Criswell LA
  24. Amos CI
  25. Seldin MF
  26. Kastner DL
  27. Ardlie KG
  28. Alfredsson L
  29. Costenbader KH
  30. Altshuler D
  31. Huizinga TW
  32. Shadick NA
  33. Weinblatt ME
  34. de Vries N
  35. Worthington J
  36. Seielstad M
  37. Toes RE
  38. Karlson EW
  39. Begovich AB
  40. Klareskog L
  41. Gregersen PK
  42. Daly MJ
  43. Plenge RM
  Common variants at CD40 and other loci confer risk of rheumatoid arthritis.; Nature genetics; Vol 40(10). 2008 Oct.
• 1. Korman BD
  2. Kastner DL
  3. Gregersen PK
  4. Remmers EF
  STAT4: genetics, mechanisms, and implications for autoimmunity.; Current allergy and asthma reports; Vol 8(5). 2008 Sep.
• 1. Korman BD
  2. Alba MI
  3. Le JM
  4. Alevizos I
  5. Smith JA
  6. Nikolov NP
  7. Kastner DL
  8. Remmers EF
  9. Illei GG
  Variant form of STAT4 is associated with primary Sjögren's syndrome.; Genes and immunity; Vol 9(3). 2008 Apr.
• 1. Robinson MR
  2. Korman BD
  3. Korman NJ
  Combination immunosuppressive therapies: the promise and the peril.; Archives of dermatology; Vol 143(8). 2007 Aug.